FDA allows marketing of first-of-kind computerized cognitive tests to help assess cognitive skills after a head injury - FDA Press Releases

The U.S. Food and Drug Administration today permitted marketing of two new devices to assess a patient’s cognitive function immediately after a suspected brain injury or concussion. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric are the first medical devices permitted for marketing that are intended to assess cognitive function following a possible concussion. They are intended as part of the medical evaluation that doctors perform to assess signs and symptoms of a head injury.

from Food and Drug Administration--Press Releases http://ift.tt/2bx8mhw
via IFTTT